The first patient has been dosed in the phase 3 TERZO trial of Copiktra for relapsed or refractory nodal T-follicular helper ...

The hematology diagnostics market plays a crucial role in the healthcare industry by providing essential tools for analyzing blood components, diagnosing blood-related disorders, and monitoring ...

The scientists discovered that the ingredient in such drinks boosts energy, but to the disadvantage of people with cancer.

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

The family of eight-year-old Lynn Gakure is requesting the public to help them raise KSh 9 million to take their daughter for ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...

WITH a new puppy and a night-shift job, Hannah Coggles put her constant exhaustion down to her hectic routine. When her ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

Reprogramming Cancer Cells to Treat an Aggressive Type of Leukemia Apr. 16, 2025 — A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood ...

A study initiated by a University of Arizona Comprehensive Cancer Center physician-scientist defined for the first time how ...

Silicon Valley has a grand vision of AI replacing doctors. But this story isn’t about that. Instead, it’s a story about ...